Stockreport

Aptar's Nasal Vaccine Delivery Solutions Featured in CastleVax Phase II Clinical Trial of an Intranasal COVID-19 Vaccine Candidate [Yahoo! Finance]

AptarGroup, Inc.  (ATR) 
Last aptargroup, inc. earnings: 4/30 05:04 pm Check Earnings Report
US:NYSE Investor Relations: investors.aptar.com
PDF CRYSTAL LAKE, Ill., January 13, 2026 BUSINESS WIRE )--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dosing, dispensing and protect [Read more]